Background: The diagnostic accuracy of colposcopy is poor for detecting precancerous cervical lesions. Objectives: We assessed the performance of colposcopy for identifying cervical intraepithelial neoplasia grade 2 or worse (CIN2+), before and after including a dynamic spectral imaging (DSI) map that quantifies and maps acetowhitening to assist subsequent biopsy of suspicious lesions. Methods: Four hundred and twenty-five women were examined at a multi-center setting in Wales, of which 393 women were included in the final analysis. Results: For all referrals, the sensitivity of conventional colposcopy for histologically confirmed CIN2+ was 51.5%, the specificity was 92.0%, the positive predictive value was 56.7%, and the negative predictive value (NPV) was 90.4%. With the incorporation of the DSI map in predicting CIN2+, these became 84.8, 61.5, 30.8, and 95.3% respectively. The increase of sensitivity was statistically significant (p < 0.001). For the 236 women having colposcopy after low-grade (LG) cytology, with the incorporation of DSI, the sensitivity for CIN2+ increased from 27.3 to 86.4% (p < 0.001) and the NPV from 92.6 to 97.8%. Conclusions: Colposcopy with DSI results in improved sensitivity to detect CIN2+ and maintains a high NPV for all referrals and especially for those with LG referral cytology.

1.
Pretorius RG, Zhang WH, Belinson JL, Huang MN, Wu LY, Zhang X, Qiao YL: Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 430–434.
2.
Jeronimo J, Schiffman M: Colposcopy at a crossroads. Am J Obstet Gynecol 2006; 195: 349–353.
3.
Bekkers RL, van de Nieuwenhof HP, Neesham DE, Hendriks JH, Tan J, Quinn MA: Does experience in colposcopy improve identification of high grade abnormalities? Obstet Gynecol Survey 2009; 64: 97–98.
4.
Soutter WP, Diakomanolis E, Lyons D, Ghaem-Maghami S, Ajala T, Haidopoulos D, Doumplis D, Kalpaktsoglou C, Sakellaropoulos G, Soliman S, Perryman K, Hird V, Buckley CH, Pavlakis K, Markaki S, Dina R, Healy V, Balas C: Dynamic spectral imaging: improving colposcopy. Clin Cancer Res 2009; 15: 1814–1820.
5.
Louwers JA, Zaal A, Kocken M, Ter Harmsel W, Graziosi G, Spruijt J, Berkhof J, Balas C, Papagiannakis E, Snijders P, Meijer C, van Kemenade F, Verheijen R: Dynamic spectral imaging colposcopy: higher sensitivity for detection of premalignant cervical lesions. BJOG 2011; 118: 309–318.
6.
Zaal A, Louwers J, Berkhof J, Kocken M, ter Harmsel WA, Graziosi GC, Spruijt JW, Balas C, Papagiannakis E, Snijders PJ, Meijer CJLM, van Kemenade FJ, Verheijen RH: Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy. BJOG 2012; 119: 537–544.
7.
Gage JC, Hanson VW, Abbey K, Dippery S, Gardner S, Kubota J, Schiffman M, Solomon D, Jeronimo J; ASCUS LSIL Triage Study (ALTS) Group: Number of cervical biopsies and sensitivity of colposcopy. Obstet Gynecol 2006; 108: 264–272.
8.
Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM: Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085–2092.
9.
Department of Health. Annual HPV Vaccine Coverage in England: 2012–2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/266207/HPV_AnnualDataTable2012_13_AT_acc5.pdf (accessed February 15, 2014).
10.
Public Health Wales. Latest Quarterly Report for the Uptake of Routine Childhood Immunisations in Wales. 2013. http://www.wales.nhs.uk/sitesplus/888/news/29039 (accessed February 15, 2014).
11.
Van Effelterre TP, Hogea C, Taylor SM: Projected impact of CervarixTM vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom. Hum Vaccin Immunother 2016; 12: 8–19.
12.
Zorzi M, Del Mistro A, Farruggio A, de’Bartolomeis L, Frayle-Salamanca H, Baboci L, Bertazzo A, Cocco P, Fedato C, Gennaro M, Marchi N, Penon MG, Cogo C, Ferro A: Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study. BJOG 2013; 120: 1260–1267.
13.
Cervical Screening Wales. Annual Statistical Report 2014–2015. 2015. https://www.cervicalscreeningwales.wales.nhs.uk/statistical-reports (accessed June 22, 2017).
14.
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE: Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 2011; 103: 368–383.
15.
Coronado PJ, Fasero M: Colposcopy combined with dynamic spectral imaging. A prospective clinical study. Eur J Obstet Gynecol Reprod Biol 2016; 196: 11–16.
16.
NICE: Adjunctive Colposcopy Technologies for Examination of the Uterine Cervix – DySIS and the Niris Imaging system. National Institute for Health and Clinical Excellence. Diagnostic consultation document. 2012. http://publications.nice.org.uk/adjunctive-colposcopy-technologies-for-examination-of-the-uterine-cervix-dysis-and-the-niris-dg4 (accessed March 30, 203).
17.
Louwers JA, Zaal A, Kocken M, Berkhof J, Papagiannakis E, Snijders PJ, Meijer CJ, Verheijen RH: The performance of dynamic spectral imaging colposcopy depends on indication for referrals. Gynecol Oncol 2015; 139: 452–457.
18.
Fay MP: Two-sided exact tests and matching confidence intervals for discrete data. R Journal 2010; 2: 53–58.
19.
Cervical Screening Wales. KC53/61/65 Statistical Report – Adroddiad Ystadegol 2012–2013. 2014. http://www.screeningservices.org.uk/csw/prof/reports/KC53–61–65_12–13.pdf (accessed January 28, 2014).
20.
Health and Social Care Information Centre. Cervical screening programme, England. Statistics for 2014–2015. 2015. http://content.digital.nhs.uk/catalogue/PUB18932/nhs-­cervical-stat-eng-2014–15-rep.pdf (accessed June 20, 2017).
21.
KC53/61/65 Statistical Report – Cervical Screening Wales 2013/14. www.cervical​screeningwales.wales.nhs.uk/opendoc/​248029 (accessed January , 2018).
22.
Cervical Screening Programme, England – 2014–2015. NHS Digital. https://digital.nhs.uk/catalogue/PUB18932. (accessed January 26, 2018).
23.
Roensbo MT, Hammer A, Blaakær J: Can dynamic spectral imaging system colposcopy replace conventional colposcopyin the detection of high-grade cervical lesions? Acta Obstet Gynecol Scand 2015; 94: 781–785.
24.
Arbyn M, Ronco G, Meijer CJ, Naucler P: Trials comparing cytology with human papillomavirus screening. Lancet Oncol 2009; 10: 935–936.
25.
Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P: Rate of cervical cancer , severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme. BMJ 2010; 340:c1804.
26.
Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE: Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 2011; 12: 663–672.
You do not currently have access to this content.